Pediatrics Doctors in Nottingham, MD Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Smita N Vazarkar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4924 Campbell Blvd Ste 200, Nottingham, MD 21236 Phone: 443-442-2300

Christina Margaret Brown, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4920 Campbell Blvd, Nottingham, MD 21236 Phone: 410-933-7600    Fax: 410-933-7601

Ethel Mojoko, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4924 Campbell Blvd, #200, Nottingham, MD 21236 Phone: 443-442-2300

Kristen Shaw Deitchman, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 4924 Campbell Blvd, Suite 200, Nottingham, MD 21236 Phone: 443-442-2300    Fax: 410-367-2035

Dr. Anthony F Pinto Iii, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4924 Campbell Blvd Ste 200, Nottingham, MD 21236 Phone: 443-442-2300

Dr. Richard Laroy Dietrich, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4920 Campbell Blvd, Kaiser Permanente White Marsh Medical Center, Nottingham, MD 21236 Phone: 410-933-7600    Fax: 410-933-7802

Dr. Judith Rubin Dejarnette, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4920 Campbell Blvd, Nottingham, MD 21236 Phone: 410-933-7600

News Archive

Study on influenza B viruses could help make flu vaccination programs more effective

An analysis of 10 years' worth of data on human influenza B viruses has shed new light on the pathogen which can cause the seasonal flu. Findings from this study could help make flu immunization programs more effective; by better targeting vaccines or by eventually eliminating one of the flu lineages completely.

FDA Advisory Committee recommends approval of Merck's VICTRELIS for chronic HCV genotype 1 infection

Merck announced today that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously that the available data support approval of Merck's investigational medicine VICTRELIS™ (boceprevir) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection in combination with current standard therapy.

Immediate response required to curb spread of artemisinin-resistant malaria in Burma

In this Wall Street Journal opinion piece, Jay Winsten, associate dean at the Harvard School of Public Health, and Trish Stroman, a principal at the Boston Consulting Group, examine "the emergence in Southeast Asia of malarial parasites resistant to artemisinin - the current gold-standard drug for treating the disease," writing it "poses grave new challenges."

Researchers identify novel blood-based markers to detect Alzheimer's disease

In a recent study published in the Journal of Alzheimer's Disease, researchers at Okayama University developed a technique to uncover molecules within the blood which can help doctors differentiate patients with Alzheimer's disease from healthy individuals.

Scientists explore how nanoscale topographies affect cellular regenerative responses

Researchers are trying to find ways to control cellular response in vitro using engineered materials in a continuous pursuit to regenerate injured or diseased tissues.

Read more Medical News

› Verified 2 days ago